BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:TE-8105 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of TE-8105\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07857473-261@assetmemo.bio
DTSTAMP:20261121T005813Z
DTSTART;VALUE=DATE:20280229
DTEND;VALUE=DATE:20280301
SUMMARY:TE-8105: Phase 2 readout est. (NCT07857473)
DESCRIPTION:TE-8105\, phase 2\, Obesity.\nStudy: A Study to Investigate the
  Safety and Efficacy of TE-8105 in Overweight or Obesity Participants\nEst
 imated primary completion: February 2028. This is a ClinicalTrials.gov est
 imate\, not a confirmed readout date\, and it can move.\nDrug page: https:
 //assetmemo.bio/drug/te-8105#upcoming-events\nRegistry record: https://cli
 nicaltrials.gov/study/NCT07857473
URL:https://assetmemo.bio/drug/te-8105#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
